Genentech: The Beginnings of Biotech [Synthesis] - Hughes, Sally Smith - Good

uncommonly
(2209)
Geregistreerd als particuliere verkoper
Voorschriften voor consumentenbescherming die voortvloeien uit Europese consumentenwetgeving, zijn derhalve niet van toepassing. eBay-kopersbescherming geldt nog steeds voor de meeste aankopen.
Andere objecten van verkoper
Contact opnemen met verkoper
US $3,08
OngeveerEUR 2,62
of Beste voorstel
Was US $3,50 (12% korting)Wat betekent deze prijs?
Recente verkoopprijs (door de verkoper verstrekt)
Objectstaat:
Heel goed
Snel, anders bent u te laat. 1 persoon volgt dit object.
Ophalen:
Gratis ophalen op deze locatie: Long Beach, New York, Verenigde Staten.
Verzendkosten:
US $4,47 (ongeveer EUR 3,81) USPS Media MailTM.
Bevindt zich in: Long Beach, New York, Verenigde Staten
Levering:
Geschatte levering tussen vr, 10 okt en vr, 17 okt tot 94104
De levertijd wordt geschat met onze eigen methode op basis van onder meer de nabijheid van de koper ten opzichte van de objectlocatie, de geselecteerde verzendservice, en de verzendgeschiedenis van de verkoper. De leveringstermijnen kunnen variëren, vooral gedurende piekperiodes.
Retourbeleid:
Geen retourzendingen geaccepteerd.
Betalingen:
     Diners Club

Winkel met vertrouwen

Geld-terug-garantie van eBay
Ontvang het object dat u hebt besteld of krijg uw geld terug. Meer informatieGeld-terug-garantie van eBay - nieuw venster of tabblad
De verkoper neemt de volledige verantwoordelijkheid voor deze aanbieding.
eBay-objectnummer:256864880534

Specificaties

Objectstaat
Heel goed: Een boek dat er niet als nieuw uitziet en is gelezen, maar zich in uitstekende staat ...
ISBN
9780226045511

Over dit product

Product Identifiers

Publisher
University of Chicago Press
ISBN-10
022604551X
ISBN-13
9780226045511
eBay Product ID (ePID)
28038271795

Product Key Features

Book Title
Genentech : the Beginnings of Biotech
Number of Pages
232 Pages
Language
English
Topic
Biotechnology, Industries / General, History, Corporate & Business History
Publication Year
2013
Genre
Science, Business & Economics
Author
Sally Smith Hughes
Book Series
Synthesis Ser.
Format
Trade Paperback

Dimensions

Item Height
0.1 in
Item Weight
11.9 Oz
Item Length
0.9 in
Item Width
0.6 in

Additional Product Features

Intended Audience
Trade
Dewey Edition
22
Reviews
Drawing extensively on oral histories, Hughes reveals the day-to-day hands-on roles of both the venture capitalists and the scientists, their eyes fixed at once on scientific triumphs and corporate riches, who brought Genentech to life. Hughes vividly recounts the tough-minded deals, buccaneering strategies, laboratory struggles, and relentless patent arrangements that not only made for Genentech's success but that pioneered the new biotechnology industry's operational model., Sally Smith Hughes's book on the formative years of Genentech helps fill a gaping hole in the history of biotechnology, as it grew out of the recombinant DNA technology in the 1970s and 1980s. This book covers the quake from its epicenter. It draws on two decades of research, thousands of conversations, hundreds of documents, and dozens of oral history interviews. This zippy read will be welcomed by those who care about the San Francisco Bay area, biotechnology, the history of molecular biology, and high-tech economic development. Genentech has long had its legends, statues, buildings, and view of Candlestick Park; now it has a book about its beginnings., [A]n eminently readable (and, for classes, eminently assignable) story . . . . Smith Hughes is one of the foremost oral historians of science today, and Genentech is filled with illuminating interview snippets woven artfully into a narrative that both engages and (somewhat surreptitiously) analyzes. . . . [F]or a case study that lays out in lively detail the ambiguities and exuberances of high-tech entrepreneurship, Smith Hughes's Genentech surely ranks among the very best., Sally Smith Hughes skillfully describes the improbable creation, difficult adolescence, immense prosperity, and eventual foundering of Genentech, the first biotech behemoth. It's a great tale, with a cast of fabulous characters and surprising episodes, ranging from Palo Alto to Wall Street. This is an outstanding book that should appeal to Nobel laureates as well as hedge-fund barons and ordinary citizens., [A] fascinating book, vividly recount[ing] the blood, sweat, and tears of the early days of 'genetic engineers' working at the bench, designing new biomolecules, and capitalizing their promises on Wall Street., My first job out of my postdoc was at Genentech in early 1981. At the time, I had no idea that all those guys in suits were doing something that had never been done before. But I did know the science was amazing--and Bob Swanson was the clear leader in creating an environment that supported that science. Sally Smith Hughes has brought to life the details of what the key players were up to--they weren't playing it safe, and they created a catalytic environment that generated a whole new industry., Sally Smith Hughes skillfully describes the improbable creation, difficult adolescence, immense prosperity, and eventual foundering of Genentech, the first biotech behemoth. It's a great tale, with a cast of fabulous characters and surprising episodes, ranging from Palo Alto to Wall Street. This is an outstanding book that should appeal to Nobel laureates as well as hedge-fund barons and ordinary citizens., Genentech: The Beginnings of Biotech paints a wonderfully detailed picture of an important beginning in the history of biotechnology., The author skillfully reveals the practical, day-to-day, hands-on roles played by venture capitalists focused on fiscal gain and scientists focused on scientific breakthroughs. . . . [A] fascinating read., My first job out of my postdoc was at Genentech in early 1981. At the time, I had no idea that all those guys in suits were doing something that had never been done before. But I did know the science was amazing-and Bob Swanson was the clear leader in creating an environment that supported that science. Sally Smith Hughes has brought to life the details of what the key players were up to-they weren't playing it safe, and they created a catalytic environment that generated a whole new industry., Hughes's Genentech makes an invaluable international contribution to understanding how a period just short of a decade redefined 'business as usual' for biologists., Hughes has crafted an engaging historical account of Genentech from its beginnings as a small laboratory at the University of California, San Francisco to the 2009 merger with Roche for 47 billion dollars. . . . [Her] account will appeal to a broad audience and is a must read for scholars interested in the history of biotechnology. Highly recommended., Over the past 20 years Sally Smith Hughes has done a great service to science studies by conducting in-depth oral-history interviews with prominent scientists, venture capitalists, corporate leaders, and attorneys in the history and business of early biotechnology. She drew on her unprecedented access to corporate records and a large number of actors and their oral histories to write Genentech , the first comprehensive account of the creation and early development of the Genentech Corporation.
Dewey Decimal
338.7/66060973
Table Of Content
Prologue Acknowledgments 1 / Inventing Recombinant DNA Technology Two Scientists on Converging Paths The Collaboration Patenting and Politics Steps toward Commercialization 2 / Creating Genentech Bob Swanson Founding Genentech Legal and Political Obstacles A Full Business Plan 3 / Proving the Technology A Portentous Experiment Switching Targets Negotiating Research Agreements Making Somatostatin Wider Issues 4 / Human Insulin: Genentech Makes its Mark Seeking Corporate Contracts Procuring a Facility and Staff Genentech''s Human Insulin Project The Eli Lilly Contract Publicity and Expansion 5 / Human Growth Hormone: Shaping a Commercial Future Competing for Human Growth Hormone Moving toward Corporate Integration Scaling Up Insulin and Growth Hormone Corporate Expansion An Emerging Culture 6 / Wall Street Debut Biomania Exit Strategies Interferon: The New Wonder Drug? Run-up to an Initial Public Offering Legal Impediments The IPO Epilogue Notes Bibliography Oral History Bibliography Index
Synopsis
In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading, at that point the largest gain in stock market history. Coming at a time of economic recession and declining technological competitiveness in the United States, the event provoked banner headlines and ignited a period of speculative frenzy over biotechnology as a revolutionary means for creating new and better kinds of pharmaceuticals, untold profit, and a possible solution to national economic malaise. Drawing from an unparalleled collection of interviews with early biotech players, Sally Smith Hughes offers the first book-length history of this pioneering company, depicting Genentech's improbable creation, precarious youth, and ascent to immense prosperity. Hughes provides intimate portraits of the people significant to Genentech's science and business, including cofounders Herbert Boyer and Robert Swanson, and in doing so sheds new light on how personality affects the growth of science. By placing Genentech's founders, followers, opponents, victims, and beneficiaries in context, Hughes also demonstrates how science interacts with commercial and legal interests and university research, and with government regulation, venture capital, and commercial profits. Integrating the scientific, the corporate, the contextual, and the personal, Genentech tells the story of biotechnology as it is not often told, as a risky and improbable entrepreneurial venture that had to overcome a number of powerful forces working against it.
LC Classification Number
HD9999.B444

Objectbeschrijving van de verkoper

Over deze verkoper

uncommonly

97,4% positieve feedback•3,8K objecten verkocht

Lid geworden op dec 1998
Reageert meestal binnen 24 uur
Geregistreerd als particuliere verkoperDus de consumentenrechten die voortvloeien uit EU-wetgeving voor consumentenbescherming zijn niet van toepassing. eBay-kopersbescherming geldt nog steeds voor de meeste aankopen.
uncommonly uncommon and common goods
Winkel bezoekenNeem contact met ons op

Gedetailleerde verkopersbeoordelingen

Gemiddelde van de afgelopen 12 maanden
Nauwkeurige beschrijving
5.0
Redelijke verzendkosten
4.9
Verzendtijd
5.0
Communicatie
5.0

Populaire rubrieken in deze winkel

Alles bekijkenrubrieken
ArtAntiquesFurnitureBooks & VideosElectronicsToolsClothingKitchenLiving Room

Feedback verkoper (1.861)

Alle beoordelingen
Positief
Neutraal
Negatief
Alle feedback weergeven